We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer discusses.
Back in 2024, on May 15, Mad Money’s Jim Cramer discussed how some long-time outperformers were being overlooked, reemphasizing his confidence in Danaher Corporation after its recent spin-off of Veralto, saying:
“Danaher — this is one of the great performers of all time. Only up 20%. It’s now a pure play on diagnostics and medical equipment, which is very fast-growing. Last fall, Danaher spun off its water purification and applied solutions businesses as Veralto. Both stocks are now lagging the S&P 500, but given how these stories usually play out, I think it could be a terrific buying opportunity to pick up Danaher. […]
Do not overlook that stock. These guys know how to run a company.”
His conviction didn’t pan out here, with the stock falling 25.95% and underperforming peers. Danaher Corporation is underperforming despite a clear focus on diagnostics and medical devices following its recent corporate refocus.
A healthcare professional in a lab coat holding a microscope and looking at a slide under the lens.
Here’s what Cramer said about the stock on April 22:
“I was surprised at Danaher, which I felt that Danaher’s one of the worst stocks I’ve ever had after being for years one of the best stocks. But that was because of China so I was gratified to see that they kept things okay.”
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
This article is originally published at Insider Monkey.
